BD Diagnostics, Bruker Partner on Microbial Identification Technologies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BD Diagnostics and Bruker Daltonics jointly announced today a co-development and co-marketing agreement for microbial identification technologies.

The firms said that they will promote an emerging, integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing through a combination of their technologies. The collaboration will combine Bruker's MALDI Biotyper microbial identification system with BD's Phoenix Microbiology System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.